Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

A CLL (Chronic Lymphocytic Leukemia) Patient Tells Her Story About Being Immune Compromised During the COVID-19 Pandemic and Accessing Regen-Cov (Casirivimab and Imdevimab) for Protection

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

For CLL / SLL patients, many of whom lived pretty everyday lives despite having incurable cancer, the COVID-19 pandemic changed everything by shining a light on the vulnerability of the immunocompromised.

Jill Gollinger, a CLL patient, wrote this article for her local community magazine about her push to get accepted into the Compassionate Use Program to prevent COVID-19 by receiving monthly infusions of Regen-Cov. She is hoping to avoid the same fearful news as Jill received. To learn more about Regeneron’s robust Compassionate Use Program, click here.

We learn from this intelligent and brave patient how COVID turned over her lives and her reactions to the threat.

Please, if you haven’t already, review, complete, and print our COVID ACTION PLAN. It could be lifesaving.

Stay strong.  We are all in this together.


Brian Koffman MDCM (retired) MS Ed (he, him, his)
Co-Founder, Executive VP and Chief Medical Officer
CLL Society, Inc.

CLL Society - COVID-19

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.